Recently, it was shown in prostate cancer that patients’ plasma samples presented significantly higher STEAP1-positive EVs compared to healthy individuals, as analyzed by nanoscale flow cytometry (Khanna et al., 2021). The gene discussed is STEAP1; the disease is Familial prostate cancer.